Home>Topics>>UPDATE 1-OPKO Health to buy Israel's Prolor Biotech for $480 mln

UPDATE 1-OPKO Health to buy Israel's Prolor Biotech for $480 mln

Reuters: Hot Stocks

Wed, 24 Apr 2013

* Prolor's hGH-CTP has completed four clinical trials (Adds CEO quotes, details, share reaction)

Related Topics:

  1. Biotechnology
  2. Chief Executive

Related Videos

  1. Buffett's Succession Plan Should Have Little Downside

    Tue, 30 Apr 2013

    Although the public is still uncertain who will succeed the Oracle, the split-up of the chairman, CEO , and investment roles likely won't alter Berkshire's overall strategy.

Content Partners